Ember Therapeutics, Inc. (EMBT)

Other OTC - Other OTC Delayed Price. Currency in USD

0.0001

0.0000

(0.00%)

At close: 10:02AM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.0001
Open	0.0001
Bid	0.0000 x 0
Ask	0.0000 x 0
Day's Range	0.0001 - 0.0001
52 Week Range	0.0001 - 0.0002
Volume	3,200
Avg. Volume	69

Market Cap	926,875
Beta (5Y Monthly)	N/A
PE Ratio (TTM)	N/A
EPS (TTM)	-0.0000
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for EMBT

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

EMBER THERAPEUTICS INC
MANH: What does Argus have to say about MANH?MANHATTAN ASSOCIATES INC has an Investment Rating of BUY; a target price of $223.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.
Rating
Fair Value
Economic Moat
8 days agoArgus Research